Autism Spectrum Disorders is an umbrella term, commonly used for several neurodevelopmental disorders, such as Autism, Asperger’s syndrome, Rett syndrome, and Childhood Disintegrating Disorders, to name a few. It is characterized with an altered pattern of social communication, perception, concentration, and behavioral aspects, with a wide range of symptoms and severity. In majority of the cases, the signs of ASD like reduced eye contact, lack of response to their names, etc., are being displayed in early infancy. At the same time, signs of epilepsy, intellectual disability, gastrointestinal problems, anxiety, depression, weak communication, etc., are quite apparent by the age of 2 years. Clinical investigations have confirmed that the pathological abnormality in all forms of ASD is associated with an early-age altered development of neuronal circuitry, either due to genetic variations or due to environmental triggers, like immune dysregulation, exposure to toxic metals, nutritional deficiency, as well as hormonal imbalances.

Although, the conventionally available treatment options are only symptomatic, with limited therapeutic goals, the advent of Stem Cell treatment for Autism has presented a new hope to further our understanding of the complexities and the root cause of Autism Spectrum Disorder development. Thus, through our understanding of the science behind stem cell therapy for Autism treatment, we have observed that most of the Autism Children treated with a combination of stem cells and other supportive therapies can show visible signs of improvements in social interactions, communication, attention span, and mental development, thus making stem cell therapy potentially the best treatment for Autism.

Stem Cell Treatment for Autism: Advancells Protocol

At Advancells, we have identified the unlimited potential of stem cells isolated from different Autologous sources of human bodies, including Bone Marrow, Adipose Tissue, etc. With our advanced Technical Support, Scientific Excellence and Competent Quality Management System, we are focused to provide a comprehensive personalized therapeutic solution, best suited for individual requirements of children undergoing treatment for ASD.

With extensive research these challenges are now comprehensible to therapeutic ventures resulting in new treatments of Autism using autologous treatment/allogenic transplant for adipose-derived mesenchymal stromal cells treatment and bone marrow stromal cells treatment. This new insight on the treatment of Autism has helped in identifying the potential to overcome Autism with stem cells, primarily using autologous stem cell transplant in form of hematopoietic stem cell transplant or mesenchymal stromal cells treatment.